Vivos Therapeutics Inc. (NASDAQ:VVOS) saw its stock soar by 90% following a major regulatory win: the company’s VidaSleep ...

Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and ...

Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other ...

Woodland Heights Medical Center is committed to helping patients get a better night's sleep, offering a surgical treatment ...

With more than 1 in 10 Americans suffering from obstructive sleep apnea putting them at increased risk of heart problems and ...

A new strategic commercial agreement unites DarioHealth’s clinically validated cardiometabolic and behavioral artificial intelligence-powered health solutions with GreenKey’s “sleep-first” approach ...